Emerging links between type 2 diabetes and Alzheimer's disease

被引:89
|
作者
Sridhar, Gumpeny R. [1 ]
Lakshmi, Gumpeny [1 ]
Nagamani, Gumpeny [1 ]
机构
[1] Andhra Med Coll, Endocrine & Diabet Ctr, Dept Obstet & Gynecol, Visakhapatnam 530002, Andhra Pradesh, India
来源
WORLD JOURNAL OF DIABETES | 2015年 / 6卷 / 05期
关键词
Cognition; Insulin resistance; Insulin; Butyrylcholinesterase; Dementia;
D O I
10.4239/wjd.v6.i5.744
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes mellitus and Alzheimer's disease are both associated with increasing age, and each increases the risk of development of the other. Epidemiological, clinical, biochemical and imaging studies have shown that elevated glucose levels and diabetes are associated with cognitive dysfunction, the most prevalent cause of which is Alzheimer's disease. Cross sectional studies have clearly shown such an association, whereas longitudinal studies are equivocal, reflecting the many complex ways in which the two interact. Despite the dichotomy, common risk and etiological factors (obesity, dyslipidemia, insulin resistance, and sedentary habits) are recognized; correction of these by lifestyle changes and pharmacological agents can be expected to prevent or retard the progression of both diseases. Common pathogenic factors in both conditions span a broad sweep including chronic hyperglycemia per se, hyperinsulinemia, insulin resistance, acute hypoglycemic episodes, especially in the elderly, microvascular disease, fibrillar deposits (in brain in Alzheimer's disease and in pancreas in type 2 diabetes), altered insulin processing, inflammation, obesity, dyslipidemia, altered levels of insulin like growth factor and occurrence of variant forms of the protein butyrylcholinesterase. Of interest not only do lifestyle measures have a protective effect against the development of cognitive impairment due to Alzheimer's disease, but so do some of the pharmacological agents used in the treatment of diabetes such as insulin (especially when delivered intranasally), metformin, peroxisome proliferator-activated receptors. agonists, glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors. Diabetes must be recognized as a risk for development of Alzheimer's disease; clinicians must ensure preventive care be given to control and postpone both conditions, and to identify cognitive impairment early to manage it appropriately. (C) The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
引用
下载
收藏
页码:744 / 751
页数:8
相关论文
共 50 条
  • [31] Adiposity, Type 2 Diabetes, and Alzheimer's Disease
    Luchsinger, Jose A.
    Gustafson, Deborah R.
    JOURNAL OF ALZHEIMERS DISEASE, 2009, 16 (04) : 693 - 704
  • [32] Linking type 2 diabetes and Alzheimer's disease
    Han, Weiping
    Li, Cai
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (15) : 6557 - 6558
  • [33] Connecting Type 2 diabetes to Alzheimer's disease
    De Felice, Fernanda G.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (12) : 1297 - 1299
  • [34] Assessing the Clinical Correlation between Alzheimer's disease and Type-2 Diabetes Mellitus: Current Strategies and Emerging Perspectives
    Parekh, Janvi
    Shende, Himani
    Kumar, Ajay
    Tuli, Hardeep Singh
    Kaur, Ginpreet
    CURRENT PHARMACOLOGY REPORTS, 2024, 10 (02) : 145 - 158
  • [35] CDK5: The Connection Between Alzheimer's Disease and Type 2 Diabetes?
    Mora, Kevin Edgar
    Aguanno, Ann
    FASEB JOURNAL, 2018, 32 (01):
  • [36] Bidirectional links between Alzheimer's disease and Niemann-Pick type C disease
    Malnar, Martina
    Hecimovic, Silva
    Mattsson, Niklas
    Zetterberg, Henrik
    NEUROBIOLOGY OF DISEASE, 2014, 72 : 37 - 47
  • [37] Neuronal stress signaling and eIF2α phosphorylation as molecular links between Alzheimer's disease and diabetes
    Lourenco, Mychael V.
    Ferreira, Sergio T.
    De Felice, Fernanda G.
    PROGRESS IN NEUROBIOLOGY, 2015, 129 : 37 - 57
  • [38] Iron, type 2 diabetes mellitus, and Alzheimer’s disease
    Luca Mascitelli
    Francesca Pezzetta
    Mark R. Goldstein
    Cellular and Molecular Life Sciences, 2009, 66 : 2943 - 2943
  • [39] Type 2 Diabetes Mellitus, Dyslipidemia, and Alzheimer's Disease
    Carlsson, Cynthia M.
    JOURNAL OF ALZHEIMERS DISEASE, 2010, 20 (03) : 711 - 722
  • [40] Iron, type 2 diabetes mellitus, and Alzheimer's disease
    Mascitelli, Luca
    Pezzetta, Francesca
    Goldstein, Mark R.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2009, 66 (17) : 2943 - 2943